GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » StemCell Institute (TSE:7096) » Definitions » Degree of Operating Leverage

StemCell Institute (TSE:7096) Degree of Operating Leverage : 0.98 (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is StemCell Institute Degree of Operating Leverage?

Degree of Operating Leverage (DOL) measures the percentage change in EBIT for a unit change in Revenue. StemCell Institute's Degree of Operating Leverage for the quarter that ended in Sep. 2024 was 0.98. The higher Degree of Operating Leverage, the higher operating risk the company will take.

The industry rank for StemCell Institute's Degree of Operating Leverage or its related term are showing as below:

TSE:7096's Degree of Operating Leverage is ranked worse than
66.59% of 880 companies
in the Biotechnology industry
Industry Median: -0.02 vs TSE:7096: 0.98

StemCell Institute Degree of Operating Leverage Historical Data

The historical data trend for StemCell Institute's Degree of Operating Leverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

StemCell Institute Degree of Operating Leverage Chart

StemCell Institute Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Degree of Operating Leverage
Get a 7-Day Free Trial 1.68 7.08 -13.52 2.30 2.09

StemCell Institute Quarterly Data
Mar18 Mar19 Dec19 Mar20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
Degree of Operating Leverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.84 1.93 1.64 2.09 0.98

Competitive Comparison of StemCell Institute's Degree of Operating Leverage

For the Biotechnology subindustry, StemCell Institute's Degree of Operating Leverage, along with its competitors' market caps and Degree of Operating Leverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


StemCell Institute's Degree of Operating Leverage Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, StemCell Institute's Degree of Operating Leverage distribution charts can be found below:

* The bar in red indicates where StemCell Institute's Degree of Operating Leverage falls into.


;
;

StemCell Institute Degree of Operating Leverage Calculation

StemCell Institute's Degree of Operating Leverage for the quarter that ended in Sep. 2024 is calculated as:

Degree of Operating Leverage=% Change in EBIT**/% Change in Revenue
=( 198.468 (Sep. 2024) / 348.964 (Sep. 2023) - 1 )/( 1267.634 (Sep. 2024) / 2268.443 (Sep. 2023) - 1 )
=-0.4313/-0.4412
=0.98***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of EBIT and Revenue was used to calculate Degree of Operating Leverage.
*** Please be aware that the Degree of Operating Leverage calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


StemCell Institute  (TSE:7096) Degree of Operating Leverage Explanation

Degree of Operating Leverage (DOL) is a leverage ratio that measures the sensitivity of a company’s operting income, also referred to as Earnings Before Interest and Taxes (EBIT), to fluctuations in its Revenue. DOL is a method used to quantify a company’s operating risk. This risk is related to the company's structure of variable costs and fixed costs. Since the fixed costs do not allow the company to adjust the operating costs, the operating risk rises with a higher fixed-to-variable costs proportion.

A high Degree of Operating Leverage indicates that the company’s fixed costs exceed its variable costs. By increasing the sales, the company can earn more profits. In addition, the company must be able to maintain relatively high sales to cover all fixed costs.

Be Aware

The use of operating leverage varies across different industries and business sectors, and the application of Degree of Operating Leverage (DOL) should be adjusted accordingly.


StemCell Institute Degree of Operating Leverage Related Terms

Thank you for viewing the detailed overview of StemCell Institute's Degree of Operating Leverage provided by GuruFocus.com. Please click on the following links to see related term pages.


StemCell Institute Business Description

Traded in Other Exchanges
N/A
Address
Shimbashi, Minato-ku, Tamuracho Building, Matsuoka, Tokyo, JPN, 105-0004
StemCell Institute is engaged in Cell bank business that separates and stores cord blood for regenerative medicine. Cord blood is the baby's blood contained in the umbilical cord and placenta that connects mother and baby. In its umbilical cord blood storage business, upon receiving notification from customers who have contracted, umbilical cord blood collected at obstetric facilities throughout Japan is collected, transported to the company's own cell processing center within 48 hours, and it provides a service to store cells at ultra-low temperature after separating cells from blood.

StemCell Institute Headlines

No Headlines